Antisense Therapeutics Limited Stock Market Value
| ATHJF Stock | USD 0.04 0.00 0.00% |
| Symbol | Antisense |
Antisense Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Antisense Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Antisense Therapeutics.
| 12/22/2022 |
| 12/11/2024 |
If you would invest 0.00 in Antisense Therapeutics on December 22, 2022 and sell it all today you would earn a total of 0.00 from holding Antisense Therapeutics Limited or generate 0.0% return on investment in Antisense Therapeutics over 720 days. Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia More
Antisense Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Antisense Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Antisense Therapeutics Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1139 | |||
| Maximum Drawdown | 330.62 |
Antisense Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Antisense Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Antisense Therapeutics' standard deviation. In reality, there are many statistical measures that can use Antisense Therapeutics historical prices to predict the future Antisense Therapeutics' volatility.| Risk Adjusted Performance | 0.0944 | |||
| Jensen Alpha | 3.61 | |||
| Total Risk Alpha | (1.63) | |||
| Treynor Ratio | 0.5441 |
Antisense Therapeutics Backtested Returns
Antisense Therapeutics is out of control given 3 months investment horizon. Antisense Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. We are able to break down sixteen different technical indicators, which can help you to evaluate if expected returns of 4.8% are justified by taking the suggested risk. Use Antisense Therapeutics Mean Deviation of 9.72, standard deviation of 39.12, and Risk Adjusted Performance of 0.0944 to evaluate company specific risk that cannot be diversified away. Antisense Therapeutics holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 8.4, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Antisense Therapeutics will likely underperform. Use Antisense Therapeutics treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to analyze future returns on Antisense Therapeutics.
Auto-correlation | -0.29 |
Weak reverse predictability
Antisense Therapeutics Limited has weak reverse predictability. Overlapping area represents the amount of predictability between Antisense Therapeutics time series from 22nd of December 2022 to 17th of December 2023 and 17th of December 2023 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Antisense Therapeutics price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Antisense Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | -0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Antisense Therapeutics lagged returns against current returns
Autocorrelation, which is Antisense Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Antisense Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Antisense Therapeutics returns to help us make a trade decision. For example, suppose you find that Antisense Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Antisense Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Antisense Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Antisense Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Antisense Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Antisense Therapeutics Lagged Returns
When evaluating Antisense Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Antisense Therapeutics pink sheet have on its future price. Antisense Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Antisense Therapeutics autocorrelation shows the relationship between Antisense Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Antisense Therapeutics Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Antisense Pink Sheet
Antisense Therapeutics financial ratios help investors to determine whether Antisense Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Antisense with respect to the benefits of owning Antisense Therapeutics security.